Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 2

Treatment of pruritic diseases with topical calcineurin inhibitors

Authors Sonja Ständer, Funda Schürmeyer-Horst, Thomas A Luger, Elke Weisshaar

Published 15 June 2006 Volume 2006:2(2) Pages 213—218

Sonja Ständer, Funda Schürmeyer-Horst, Thomas A Luger, Elke Weisshaar*

 

Clinical Neurodermatology, Department of Dermatology, University Hospital Münster, Germany, *Department of Social Medicine, Occupational and Environmental Dermatology, University Hospital of Heidelberg, Germany

 

Abstract: The introduction of topical calcineurin inhibitors resulted in a significant improvement in the treatment of atopic dermatitis. In addition, rapid amelioration of pruritus could be observed. In case reports, other pruritic dermatoses such as chronic irritative hand dermatitis, rosacea, graft-versus-host-disease, and lichen sclerosus were also treated successfully with pimecrolimus and tacrolimus. Twenty patients were treated with tacrolimus and pimecrolimus in a surveillance study to evaluate efficacy in pruritus and prurigo. Eighteen of 20 patients responded to therapy. Best results were obtained in localized and generalized pruritus while in prurigo nodularis only a subgroup of patients showed an improvement of pruritus. Further controlled studies are necessary to confirm these results.

 

Keywords: Pimecrolimus, tacrolimus, pruritus, itch, vanilloid receptor

Download Article [PDF] 

Readers of this article also read:

Effects of treatment with antimicrobial agents on the human colonic microflora

Fatemeh Rafii, John B Sutherland, Carl E Cerniglia

Therapeutics and Clinical Risk Management 2008, 4:1343-1357

Published Date: 5 December 2008

Acute migraine: Current treatment and emerging therapies

Arun A Kalra, Debra Elliott

Therapeutics and Clinical Risk Management 2007, 3:449-459

Published Date: 15 July 2007

Cost-effectiveness of hypothetical new cancer drugs in patients with advanced small-cell lung cancer: results of a markov chain model

Carin A Uyl-de Groot, Joseph McDonnell, Guul ten Velde, David Radice, Harry J M Groen

Therapeutics and Clinical Risk Management 2006, 2:317-323

Published Date: 15 September 2006

Editorial ||FREE PAPER||

Garry Walsh

Therapeutics and Clinical Risk Management 2006, 2:227-228

Published Date: 15 September 2006

Oral mucositis induced by anticancer treatments: physiopathology and treatments

D’Hondt, Lionel, Lonchay, Christophe, André, Marc, Canon, Jean-Luc

Therapeutics and Clinical Risk Management 2006, 2:159-168

Published Date: 15 June 2006